🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #424

Cancer - Press Review (September 29, 2012) – Revue de presse (29 septembre 2012)

#424
From: SMW
Date: Sat, 29 Sep 2012 08:05
165 lines
7817 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (September 29, 2012) – Revue de presse (29 septembre
2012)


Bizarre, Recurrent Cancer Case May Lead to Custom Care
It’s a medical nightmare: a 24-year-old man endures 350 surgeries
since childhood to remove growths that keep coming back in his throat
and have spread to his lungs, threatening his life. Now doctors have
found a way to help him by way of a scientific coup that holds promise
for millions of cancer patients.
By Marilynn Marchionne. In TIME
http://healthland.time.com/2012/09/27/bizarre-recurrent-cancer-case-may-lead-to-custom-care/

Health Buzz: Breast Cancer Analysis Shows 4 Types of the Disease
Researchers at the University of Washington have made progress in
understanding and, hopefully, treating breast cancer. In a study
published Sunday in the journal Nature, researchers identified four
genetically distinct forms of breast cancer.
In U.S. News & World Report
http://health.usnews.com/health-news/articles/2012/09/25/health-buzz-breast-cancer-analysis-shows-4-types-of-the-disease

Genes May Influence Impotence After Prostate Radiation
Preliminary research suggests genetic analysis might help men assess
their risk.
By Steven Reinberg. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/09/27/genes-may-influence-impotence-after-prostate-radiation

Doubt About Ovarian Cancer Screening
“As an advocate for women with ovarian cancer, I know that it is never
easy to tell someone that screening for this disease does more harm
than good (“Ovarian Cancer Screenings Have No Benefit, Panel Says, and
Some Risks,” news article, Sept. 11). Yet that is what the evidence
tells us and what the United States Preventive Services Task Force has
confirmed”.
In The New York Times
http://www.nytimes.com/2012/09/21/opinion/doubt-about-ovarian-cancer-screening.html?_r=0

Scientists find marijuana compound fights cancer‎‎
Scientists at California Pacific Medical Center in San Francisco have
discovered that cannabidiol has the ability of switching off DNA that
cause some cancers to spread.
By David Joseph. In Examiner
http://www.examiner.com/article/scientists-find-marijuana-compound-fights-cancer

Study Links Another Gene Variant to Male Breast Cancer
Finding offers insight into causes of disease that kills several
hundred men in US each year.
By Randy Dotinga. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/09/23/study-links-another-gene-variant-to-male-breast-cancer

Prostate cancer diagnosis and surgery can lead to anxiety, depression
and reduced quality of life‎
Men who undergo surgical removal of prostate cancer can experience
significant levels of anxiety one year after surgery, and higher
levels of anxiety appear to be linked to poor sexual satisfaction and
depression, say researchers at Mayo Clinic's campus in Florida. Their
recent study, published in the online edition of Psycho-Oncology,
suggests that men who experience high levels of "cancer-specific
anxiety" following surgery for prostate cancer could likely benefit
from counseling designed to address their worries and improve their
quality of life
In Medical Xpress
http://medicalxpress.com/news/2012-09-prostate-cancer-diagnosis-surgery-anxiety.html


Prévenir le cancer par l'ablation des seins et des ovaires
Anne Robert, une violoniste de 49 ans, a dĂ» faire un choix de vie
déchirant en 2010. Comme les risques de développer un cancer étaient
trop grands chez elle, elle a choisi l'ablation des seins et des
ovaires, à titre préventif.
Dans Canoë
http://fr.canoe.ca/artdevivre/bienetre/article1/2012/09/27/20237676-qmi.html

Traitement anti-cancer: des interactions dangereuses avec les
médicaments‎‎
Une étude de l'université de Rotterdam révèle que près de la moitié
des patients cancéreux qui y ont participé avalent, sans le savoir,
des médicaments qui sont contre-indiqués dans le cadre d'une
chimiothérapie ou d'un autre traitement anti-cancer.
Dans RTBF
http://www.rtbf.be/info/societe/detail_traitement-anti-cancer-des-interactions-dangereuses-avec-les-medicaments?id=7845724

Cancer de la prostate : les autotests de dosage du PSA interdits
Les dispositifs médicaux d’autodiagnostic par dosage du PSA (Prostate
specific Antigen) sont désormais interdits en France. L’Agence
nationale de Sécurité du Médicament et des Produits de Santé (ANSM)
vient de l’annoncer.
Dans Destination Santé
http://www.destinationsante.com/Cancer-de-la-prostate-les-autotests-de-dosage-du-PSA-interdits.html

Cancer du sein infiltrant non métastatique, recommandations
professionnelles (INCa)‎
L'Institut national du cancer (INCa) et la Société française de
Sénologie et de Pathologie Mammaire (SFSPM) ont publié en juillet 2012
des recommandations professionnelles concernant la prise en charge
thérapeutique du cancer du sein infiltrant non métastatique. Elles
visent à compléter les recommandations nationales sur le cancer du
sein in situ publiées par l'INCa en décembre 2009, et répondent à
différentes questions et cas problématiques relatifs au traitement de
cette forme de cancer du sein.
Dans CommentCaMarche.net
http://sante-medecine.commentcamarche.net/faq/7738-cancer-du-sein-infiltrant-non-metastatique-recommandations-professionnelles-inca

Le cancer, trop mortel dans les films?
Une étude prétend que ce qui est démontré dans les films et séries en
matière de cancer ne représente pas la réalité.
Dans Canoë
http://fr.canoe.ca/artdevivre/bienetre/article1/2012/09/25/20231371-bum.html










Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (09/2012)
Technical Details
Message-ID: <8876bb6f-d7b4-49eb-a223-ce1f1bd0c77c@a11g2000yqb.googlegroups.com>
Path: arc1-ca.pugleaf.net!e10ni117582833qan.0!nntp.google.com!l8no16392652qao.0!postnews.google.com!a11g2000yqb.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,cc428659c674fd40,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,UTF8
Received: by 10.224.223.84 with SMTP id ij20mr9303587qab.5.1348905943543;
        Sat, 29 Sep 2012 01:05:43 -0700 (PDT)
MIME-Version: 1.0
Received: by 10.236.87.71 with SMTP id x47mr1797636yhe.6.1348905943515; Sat,
 29 Sep 2012 01:05:43 -0700 (PDT)
Path: arc1-ca.pugleaf.net!e10ni117582833qan.0!nntp.google.com!l8no16392652qao.0!postnews.google.com!a11g2000yqb.googlegroups.com!not-for-mail
Newsgroups: be.science
Date: Sat, 29 Sep 2012 01:05:43 -0700 (PDT)
Complaints-To: groups-abuse@google.com
Injection-Info: a11g2000yqb.googlegroups.com; posting-host=81.247.218.217; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
NNTP-Posting-Host: 81.247.218.217
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.4 (KHTML, like
 Gecko) Chrome/22.0.1229.79 Safari/537.4,gzip(gfe)
Message-ID: <8876bb6f-d7b4-49eb-a223-ce1f1bd0c77c@a11g2000yqb.googlegroups.com>
Subject: Cancer - Press Review (September 29, 2012) – Revue de presse (29 septembre 2012)
From: SMW <scimedweb@mail.com>
Injection-Date: Sat, 29 Sep 2012 08:05:43 +0000
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable